Neha Dagar

Employment

• University of South Dakota

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• Uncovering the pharmacological mechanisms of bifendate against chronic kidney disease using computational pharmacology and experimental verification
  The Journal of Pharmacology and Experimental Therapeutics 2025 DOI: 10.1016/j.jpet.2025.103609
  +Save
• Esculetin and Phloretin Combination Mitigates Acute Kidney Injury-Diabetes Comorbidity via Regulating Mitophagy and Inflammation: A Dual-Pronged Approach
  Phytotherapy Research 2025 DOI: 10.1002/ptr.8489
  +Save
• Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress
  Cell Biology International 2025 DOI: 10.1002/cbin.70008
  +Save
• Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases
  Molecular Biomedicine 2025 DOI: 10.1186/s43556-025-00253-y
  +Save
• Network pharmacology combined with molecular docking and dynamics to assess the synergism of esculetin and phloretin against acute kidney injury-diabetes comorbidity
  Molecular Diversity 2025 DOI: 10.1007/s11030-024-10829-5
  +Save
• Unlocking the therapeutic potential of the NFAT pathway in kidney diseases
  Naunyn-Schmiedeberg's Archives of Pharmacology 2025 DOI: 10.1007/s00210-025-04033-x
  +Save
• Flavokawain A Attenuated Chronic Kidney Disease: Evidence From Network Pharmacology and Experimental Verification
  Cell Biology International 2025 DOI: 10.1002/cbin.70036
  +Save
• Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity
  Free Radical Research 2024 DOI: 10.1080/10715762.2024.2313738
  +Save
• Wnt/beta-catenin modulation: A promising frontier in chronic kidney disease management
  Fundamental and Clinical Pharmacology 2024 DOI: 10.1111/fcp.13031
  +Save
• ULK1 as a therapeutic target in kidney diseases: Current perspective
  Expert Opinion on Therapeutic Targets 2024 DOI: 10.1080/14728222.2024.2421762
  +Save